Major

Prenatal Tablets

Serving
1 Tablet(s)
Per container
100
Form
tablet
UPC
309045313602
DSLD
Avoid-flaggedObjective label signals
Flagged excipients
4
1 avoid · 3 caution
FDA recalls
0
no recall history
CAERS reports
2
FDA consumer events
Certifications
0
none recorded
1 avoid-level excipient · Every flag below links to the authority's published citation.

Supplement Facts

13 active ingredients
IngredientAmount% DV
Vitamin A
UNII · 81G40H8B0T
4000 IU50%
Vitamin C
UNII · PQ6CK8PD0R
100 mg167%
Vitamin D3
Vitamin DUNII · 1C6V77QF41
400 IU100%
Vitamin E
UNII · H4N855PNZ1
11 IU37%
Thiamine
ThiaminUNII · X66NSO3N35
1.5 mg88%
Riboflavin
UNII · TLM2976OFR
1.7 mg85%
Niacin
UNII · 2679MF687A
18 mg90%
Vitamin B6
UNII · KV2JZ1BI6Z
2.6 mg104%
Folate
UNII · 935E97BOY8
0.8 mg100%
Vitamin B12
UNII · 8406EY2OQA
4 mcg50%
Calcium
UNII · SY7Q814VUP
263 mg26%
Iron
UNII · E1UOL152H7
27 mg150%
Zinc
UNII · J41CSQ7QDS
25 mg167%
What this product supports · authorized claims

23 authority-backed effects

Rolled up from EFSA / FDA / NIH ODS authorized function claims on this product's active ingredients. Each row shows which ingredients contribute.

Flagged excipients

4 flagged · authority citations

  • ● AVOIDTitanium Dioxide
    color

    Banned in EU food products effective 2022-08 (Commission Regulation (EU) 2022/63) following EFSA Panel opinion that a safe daily intake could not be established due to genotoxicity concerns. Still GRAS in the US under 21 CFR 73.575 but EU position is stricter.

  • ◐ CAUTIONFD&C Red #40 Lake
    color

    EU requires the same 'attention/activity in children' warning label as Yellow 5 per Commission Regulation 1333/2008 Annex III. California enacted a public-school ban effective 2028 (AB 2316, 2024).

  • ◐ CAUTIONFD&C Yellow #6 Lake
    color

    EU requires 'attention in children' warning per Reg 1333/2008 Annex III (Southampton study 2007). Banned in Norway + Finland; allowed in US under 21 CFR 74.706 with declaration.

  • ◐ CAUTIONBHT
    preservative

    NTP 15th Report on Carcinogens (2021) classifies BHT/BHA as not listed, but BHA is 'reasonably anticipated to be a human carcinogen'. EU permits BHT with strict limits under Commission Regulation 1333/2008 Annex II.

FDA CAERS · adverse event context
2
consumer-submitted adverse event reports filed with the FDA CFSAN Adverse Event Reporting System mentioning this product or its brand.

CAERS reports are unverified consumer submissions — not adjudicated causality. Large well-known brands accumulate proportionally more reports simply due to broader use. About CAERS →

Other ingredients

Microcrystalline Cellulose · Stearic Acid · Hypromellose · Croscarmellose Sodium · Gelatin · Acacia · Maltodextrin · Talc · Triacetin · Starch · Magnesium Stearate · Dicalcium Phosphate · Mineral Oil · Sucrose · Silica · Sodium Ascorbate · Triglycerides · Tocopherols · Sodium Benzoate · Sorbic Acid · Tricalcium Phosphate · Ascorbyl Palmitate

Chemically equivalent

Same formula, different brand

Products with identical sorted (ingredient, amount) tuples.